Xiaohua Pei

596 total citations
48 papers, 426 citations indexed

About

Xiaohua Pei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaohua Pei has authored 48 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Xiaohua Pei's work include Retinoids in leukemia and cellular processes (5 papers), Lymphatic System and Diseases (4 papers) and Berberine and alkaloids research (4 papers). Xiaohua Pei is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Lymphatic System and Diseases (4 papers) and Berberine and alkaloids research (4 papers). Xiaohua Pei collaborates with scholars based in China, Japan and Canada. Xiaohua Pei's co-authors include Yubo Guo, Chunhui Wang, Yufei Liu, Tian An, Bo Yuan, Hideki Hayashi, Xiaomei Hu, Toshihiko Hirano, Norio Takagi and Kefei Hu and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Journal of Ethnopharmacology.

In The Last Decade

Xiaohua Pei

39 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohua Pei China 12 233 90 61 59 59 48 426
Weiling Pu China 11 286 1.2× 76 0.8× 97 1.6× 58 1.0× 36 0.6× 22 493
Minmin Xu China 11 166 0.7× 85 0.9× 48 0.8× 41 0.7× 56 0.9× 22 364
Shengnan Wang China 13 313 1.3× 116 1.3× 32 0.5× 40 0.7× 93 1.6× 35 663
Haiding Huang China 12 178 0.8× 57 0.6× 46 0.8× 53 0.9× 60 1.0× 16 426
Lichao Zhang China 11 181 0.8× 70 0.8× 76 1.2× 48 0.8× 55 0.9× 51 460
Jeong‐Geon Mun South Korea 14 251 1.1× 52 0.6× 45 0.7× 76 1.3× 80 1.4× 19 434
Nidarshana Chaturvedi Parashar India 13 335 1.4× 87 1.0× 45 0.7× 52 0.9× 69 1.2× 23 552
Haihong Lin China 13 260 1.1× 75 0.8× 43 0.7× 91 1.5× 94 1.6× 30 568
Ramakrishna Chintala India 4 220 0.9× 71 0.8× 46 0.8× 44 0.7× 88 1.5× 7 431
Shu‐Yi Yin Taiwan 9 220 0.9× 55 0.6× 65 1.1× 77 1.3× 83 1.4× 15 573

Countries citing papers authored by Xiaohua Pei

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Pei more than expected).

Fields of papers citing papers by Xiaohua Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Pei. The network helps show where Xiaohua Pei may publish in the future.

Co-authorship network of co-authors of Xiaohua Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Pei. A scholar is included among the top collaborators of Xiaohua Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Pei. Xiaohua Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pei, Xiaohua, et al.. (2024). Value of Carbon-Ion Radiation Therapy for Breast Cancer. International Journal of Particle Therapy. 14. 100629–100629.
2.
Zhang, Qiong, Xueqing Wu, Chunhui Wang, et al.. (2024). Hongjin Xiaojie Capsule, a Chinese patent medicine, for treating moderate to severe cyclical breast pain: A single-blind randomized controlled trial. Journal of Integrative Medicine. 22(5). 552–560.
3.
4.
Wang, Chunhui, et al.. (2023). Effects of Tuina Combined With Moxibustion on Breast Cancer-Related Lymphedema: A Randomized Cross-Over Controlled Trial. Integrative Cancer Therapies. 22. 1563487871–1563487871. 2 indexed citations
5.
Pei, Xiaohua, et al.. (2023). Mechanisms of single herbs and herbal pairs in the treatment of mammary gland hyperplasia: An integrated review. Heliyon. 9(11). e21000–e21000. 2 indexed citations
6.
7.
Chen, Nana, et al.. (2023). Breastmilk microbiome changes associated with lactational mastitis and treatment with dandelion extract. Frontiers in Microbiology. 14. 1247868–1247868. 7 indexed citations
8.
Yang, Xujie & Xiaohua Pei. (2022). Comparative efficacy of tonifying kidney on treatment of mammary gland hyperplasia: Systematic review with network meta-analysis. Phytomedicine Plus. 3(1). 100395–100395. 1 indexed citations
9.
Fu, Wei, et al.. (2022). Four types of RNA modification writers predict the prognosis of prostate cancer. Andrologia. 54(10). e14552–e14552. 3 indexed citations
10.
Liu, Jianping, et al.. (2022). Clinical Effectiveness and Safety of Chinese Herbal Medicine Compound Kushen Injection as an Add-On Treatment for Breast Cancer: A Systematic Review and Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–16. 9 indexed citations
11.
Liu, Jianping, et al.. (2021). Risk factors for lactation mastitis in China: A systematic review and meta-analysis. PLoS ONE. 16(5). e0251182–e0251182. 8 indexed citations
12.
Li, Li, et al.. (2021). Horizontal Rotary Cutting Technique for Skin Injury Avoidance in Superficial Benign Breast Masses. International Journal of General Medicine. Volume 14. 1379–1387. 3 indexed citations
13.
Guo, Qi, Xiaohua Pei, Yubo Guo, et al.. (2021). The mechanism of action of Fangji Huangqi Decoction on epithelial-mesenchymal transition in breast cancer using high-throughput next-generation sequencing and network pharmacology. Journal of Ethnopharmacology. 284. 114793–114793. 16 indexed citations
14.
Liu, Haixia, Yubo Guo, Ruyuan Zhu, et al.. (2020). Fructus Ligustri Lucidi preserves bone quality through induction of canonical Wnt/β‐catenin signaling pathway in ovariectomized rats. Phytotherapy Research. 35(1). 424–441. 14 indexed citations
15.
Liang, Shi-Bing, et al.. (2020). Chinese herbal medicine (Rupi Sanjie capsule) for the treatment of breast pain: A systematic review and meta-analysis of randomized clinical trials. Integrative Medicine Research. 10(2). 100491–100491. 2 indexed citations
16.
Yuan, Bo, Hidetomo Kikuchi, Hideki Hayashi, et al.. (2020). JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine via Modulating Cell Cycle Progression in Human Breast Cancer Cells. Frontiers in Pharmacology. 11. 1087–1087. 16 indexed citations
17.
Liu, Yufei, et al.. (2020). Targets and Mechanism Used by Cinnamaldehyde, the Main Active Ingredient in Cinnamon, in the Treatment of Breast Cancer. Frontiers in Pharmacology. 11. 582719–582719. 46 indexed citations
18.
Yuan, Bo, Mingjiang Yao, Xiao Wang, et al.. (2018). Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo. Cancer Cell International. 18(1). 113–113. 30 indexed citations
19.
Li, Qian, et al.. (2017). Effects of Brucine on the OPG/RANKL/RANK Signaling Pathway in MDA‐MB‐231 and MC3T3‐E1 Cell Coculture System. Evidence-based Complementary and Alternative Medicine. 2017(1). 1693643–1693643. 9 indexed citations
20.
Pei, Xiaohua, et al.. (2007). Clinical observation on treatment of hyperplasia of mammary gland by Lirukang Granule (利乳康颗粒). Chinese Journal of Integrative Medicine. 13(2). 120–124. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiling Pu Breakdown of academic impact, for papers by Minmin Xu Breakdown of academic impact, for papers by Shengnan Wang Breakdown of academic impact, for papers by Haiding Huang Breakdown of academic impact, for papers by Lichao Zhang Breakdown of academic impact, for papers by Jeong‐Geon Mun Breakdown of academic impact, for papers by Nidarshana Chaturvedi Parashar Breakdown of academic impact, for papers by Haihong Lin Breakdown of academic impact, for papers by Ramakrishna Chintala Breakdown of academic impact, for papers by Shu‐Yi Yin
Rankless by CCL
2026